YOLFTbeta
00

Hainan Shuangcheng Pharmaceut

002693 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

8.55CNY-0.18 (-2.06%)

Price History

Full chart

Market Stats

Previous Close8.73
Open8.61
Day Range8.46 – 9.15
52-Week Range6.36 – 12.43
Volume55.28M
Market Cap3.82B
P/E (TTM)70.92
Forward P/E0.00
EPS0.13
Dividend Yield0.00%
Beta0.48
50-Day Avg9.09
200-Day Avg8.63

About

Hainan Shuangcheng Pharmaceuticals Co., Ltd. engages in research and development, production, and sale of pharmaceutical injections, solid preparations, and raw materials in China and internationally. The company offers products for oncology and immune, alimentary canal, heart and cerebral, and vessels and metabolism. It also provides Bivalirudin, Epitifibatide, and Thymalfaxin for injection; Pregabalin capsule; and Memantine Hydrochloride tablets and Pioglitazone tablets USP. Hainan Shuangcheng Pharmaceuticals Co., Ltd. was founded in 2000 and is headquartered in Haikou, the People's Republic of China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jianming Li
  • Employees448
  • HeadquartersNo. 16 Xingguo Road, Haikou, China, 570314, China
  • Websitehttps://www.shuangchengmed.com

Leadership

  • Mr. Jianming LiGM & Employee Representative Director · b. 1956
  • Mr. Xuguang WangFinancial Director & Chief Financial Officer · b. 1968
  • Ms. Xiaofeng YuDeputy GM & Secretary of the Board · b. 1974
  • Mr. Jianlin YuanDeputy General Manager · b. 1973
  • Mr. Zhong YaoDeputy General Manager · b. 1979
  • Mr. Shiying WangDeputy General Manager · b. 1981
  • Mr. Yixiang AiDeputy General Manager · b. 1977
  • Ms. Haiyan LiDeputy General Manager · b. 1980
  • Ms. Rui WangDeputy General Manager · b. 1985
  • Ms. Yuan LiDeputy General Manager · b. 1983

Financials

Income Statement

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue88.18M112.88M133.50M129.66M149.60M161.20M230.97M145.14M246.77M337.24M346.65M269.44M320.29M274.75M235.93M174.21M276.76M
Growth (%)-+28.00%+18.27%-2.88%+15.38%+7.75%+43.28%-37.16%+70.03%+36.66%+2.79%-22.27%+18.87%-14.22%-14.13%-26.16%+58.87%
Cost of Revenue28.94M28.35M33.70M37.14M52.77M55.92M103.59M72.77M98.98M127.13M99.10M65.74M87.68M94.65M82.41M84.38M125.24M
Gross Profit59.24M84.53M99.81M92.53M96.84M105.28M127.38M72.37M147.79M210.11M247.55M203.70M232.61M180.10M153.52M89.83M151.53M
Gross Margin67.18%74.88%74.76%71.36%64.73%65.31%55.15%49.86%59.89%62.30%71.41%75.60%72.62%65.55%65.07%51.56%54.75%
Operating Expense20.49M12.98M21.86M26.37M41.94M33.41M69.97M459.96M146.92M300.35M239.66M282.46M271.15M189.11M226.67M195.96M127.46M
Operating Income38.75M71.55M77.94M66.16M54.89M71.86M57.42M-387.59M867.88K-90.24M7.89M-78.75M-38.54M-9.01M-73.15M-106.13M24.06M
Operating Margin43.94%63.38%58.38%51.02%36.69%44.58%24.86%-267.05%0.35%-26.76%2.28%-29.23%-12.03%-3.28%-31.01%-60.92%8.69%
EBITDA43.07M76.69M80.02M87.57M91.28M93.32M99.01M-340.56M63.15M-19.69M79.81M-11.26M23.00M59.84M-10.72M-44.60M70.80M
EBITDA Margin48.84%67.94%59.94%67.54%61.02%57.89%42.87%-234.65%25.59%-5.84%23.02%-4.18%7.18%21.78%-4.54%-25.60%25.58%
Net Income32.11M64.23M70.41M68.00M66.77M60.78M52.68M-388.41M6.31M-69.46M24.66M-53.33M-20.33M9.01M-50.74M-78.30M19.04M
Net Income Margin36.41%56.90%52.74%52.44%44.63%37.71%22.81%-267.62%2.56%-20.60%7.11%-19.79%-6.35%3.28%-21.51%-44.95%6.88%
R&D3.68M2.10M5.28M18.33M10.25M10.12M11.32M70.91M14.68M14.53M13.14M12.18M10.62M14.59M7.96M22.17M8.09M
R&D as % of Total Revenue4.18%1.86%3.95%14.14%6.85%6.28%4.90%48.86%5.95%4.31%3.79%4.52%3.32%5.31%3.37%12.72%2.92%
Interest Expense277.77K7.80K32.49K40.89K44.36K49.27K16.20M14.07M16.71M19.88M10.28M10.43M9.84M11.19M9.58M9.23M9.65M
Interest Expense % of Total Revenue0.31%0.01%0.02%0.03%0.03%0.03%7.01%9.69%6.77%5.90%2.97%3.87%3.07%4.07%4.06%5.30%3.49%

Balance Sheet

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets97.85M252.73M248.06M886.65M917.04M943.54M1.55B1.17B1.38B1.12B950.98M907.68M854.56M911.02M803.25M783.87M825.78M
Total Liabilities19.91M94.92M19.83M40.80M46.42M49.99M622.56M612.40M615.41M450.56M272.72M309.37M287.80M330.08M285.60M372.26M405.25M
Total Equity77.95M157.82M228.23M845.85M870.62M893.55M927.61M553.13M591.40M522.05M546.26M492.93M481.85M513.55M471.49M393.41M412.46M
Cash9.93M149.83M33.59M446.76M346.76M85.40M246.24M24.98M31.71M68.09M42.68M5.80M21.62M12.20M3.39M45.11M59.05M
Total Debt------490.00M487.00M367.00M306.00M167.26M222.66M167.25M205.30M135.00M184.50M-
Net Debt-9.93M-149.83M-33.59M-446.76M-346.76M-85.40M243.76M462.02M335.29M237.91M124.58M216.86M145.63M193.11M131.61M139.39M29.95M

Cash Flow

Currency: CNY2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow44.27M55.33M66.05M80.22M56.43M51.00M46.24M38.65M-22.54M46.84M66.58M-10.50M23.55M25.22M11.64M-40.83M60.95M
Investing Cash Flow-23.21M-9.15M-107.15M-218.00M-111.66M-277.07M-396.51M-180.40M-69.94M125.90M62.83M-71.48M32.99M-85.07M24.42M5.04M-
Financing Cash Flow-16.28M93.72M-75.09M550.02M-44.00M-36.00M440.92M-11.73M104.06M-134.05M-154.33M45.39M-40.62M44.93M-39.47M77.34M-
Capital Expenditure23.32M9.51M107.15M57.91M65.06M115.94M289.68M182.97M70.15M22.39M51.51M51.57M31.64M32.98M49.20M24.91M43.27M
Free Cash Flow20.94M45.82M-41.10M22.31M-8.63M-64.94M-243.44M-144.32M-92.69M24.45M15.08M-62.07M-8.09M-7.77M-37.56M-65.73M17.68M
Dividends Paid16.28M7.80K75.09M-44.00M36.00M43.02M25.20M7.51M16.70M10.07M9.76M9.10M11.13M8.69M7.19M7.27M
FCF to OCF47.31%82.81%-62.22%27.81%-15.29%-127.32%-526.48%-373.44%411.28%52.21%22.64%591.06%-34.33%-30.79%-322.67%161.01%29.00%
Dividend Paid to FCF77.72%0.02%-182.71%--509.92%-55.44%-17.67%-17.46%-8.10%68.28%66.78%-15.72%-112.51%-143.36%-23.13%-10.94%41.11%

Earnings

Report DateSep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 15, 2016Oct 20, 2016Feb 20, 2017Apr 27, 2017Jul 30, 2017Oct 22, 2017Feb 1, 2018Apr 27, 2018Aug 28, 2018Oct 26, 2018Dec 31, 2018Apr 18, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 29, 2020Aug 21, 2020Oct 28, 2020Dec 31, 2020Apr 29, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023May 22, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 22, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------------------------
EPS Actual0.040.050.020.060.030.060.020.050.030.050.010.040.040.04-0.03-0.02-0.50-0.41-0.02-0.020.020.04-0.01-0.04-0.03-0.09-0.02-0.01-0.020.11-0.01-0.03-0.02-0.07-0.010.02-0.02-0.040.00-0.01-0.000.030.010.01-0.03-0.12-0.02-0.02-0.05-0.10-0.02-0.020.040.050.010.02
Surprise--------------------------------------------------------
Timing---------------After-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market-------------------After-hours---After-hours-----

Key Statistics & Ratios

Market Cap3.82B
Enterprise Value3.97B
Trailing P/E70.92
Forward P/E0.00
PEG Ratio0.00
Price / Sales12.34
Price / Book8.95
EPS0.13
Book Value1.03
Revenue (TTM)309.80M
Gross Profit (TTM)170.36M
EBITDA103.11M
Profit Margin16.51%
Operating Margin15.03%
Return on Equity10.00%
Return on Assets3.97%
Shares Outstanding414.69M
Shares Float344.06M
Beta0.48
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20151×
0.10Mar 10, 2015
20141×
0.09May 22, 2014
20131×
0.10May 16, 2013

Stock Splits

  • Mar 10, 201515:10
  • May 22, 201415:10
  • May 16, 201315:10